Try our beta test site
Trial record 1 of 1 for:    PTC299 breast
Previous Study | Return to List | Next Study

PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer

This study has been completed.
United States Department of Defense
Information provided by (Responsible Party):
PTC Therapeutics Identifier:
First received: July 26, 2007
Last updated: March 1, 2016
Last verified: April 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)